The sharp fall in funding comes after a record-breaking first quarter in cash for start-ups
Caroline Gaynor, chairperson, Irish Venture Capital Association
Venture capital funding to Irish tech and life science firms slumped by 78pc in the second quarter of 2025 after a record first quarter, according to the latest figures from the Irish Venture Capital Association (IVCA).
The fall from €494m in the second quarter of 2024 to €113m in the same three-month period in 2025 is the worst recorded figure in a decade and means that funding in the first half of the year is down by 14pc – to €646m – compared to the same time last year.
